CLINICAL AND ECONOMIC EFFICIENCY OF BALANCED AMINO ACID SOLUTIONS IN THE TREATMENT OF SEPSIS-INDUCED HEPATIC AND RENAL FAILURE
Abstract
Background: Sepsis is a life-threatening condition often complicated by multi-organ failure, especially hepatic and renal dysfunction. Optimizing nutritional support is critical in improving outcomes in such patients. This study evaluates the clinical and economic impact of balanced amino acid formulations used in parenteral nutrition for patients with sepsis-induced liver and kidney failure.
References
1. Singer, M., et al. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 315(8), 801–810.
2. Rhodes, A., et al. (2017). Surviving Sepsis Campaign. Intensive Care Med, 43(3), 304–377.
3. Vincent, J. L., et al. (2021). SOAP study. Crit Care Med, 34(2), 344–353.
4. Wernerman, J. (2008). Glutamine supplementation. J Nutr, 138(10), 2040S–2044S.
5. Heyland, D. K., et al. (2003). Parenteral nutrition. JAMA, 290(10), 1233–1239.
6. Plauth, M., et al. (2006). ESPEN guidelines on enteral nutrition. Clin Nutr, 25(2), 285–294.
7. Dellinger, R. P., et al. (2021). Surviving Sepsis Campaign. Crit Care Med, 49(11), e1063–e1143.
8. Kreymann, K. G., et al. (2006). ESPEN intensive care. Clin Nutr, 25(2), 210–223.
9. Cano, N. J., et al. (2006). Parenteral nutrition: renal failure. Clin Nutr, 25(2), 295–310.
10. Druml, W. (2001). Amino acids in hepatic failure. Nutrition, 17(7–8), 556–560.
11. Haines, R. W., et al. (2019). Organ dysfunction and mortality in sepsis. AJRCCM, 200(6), 752–761.
